Ventyx Biosciences (VTYX)
(Delayed Data from NSDQ)
$2.17 USD
0.00 (0.00%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $2.17 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.48 |
EPS Last Quarter | -0.45 |
Last EPS Surprise | 21.05% |
ABR | 1.73 |
Earnings ESP
|
-0.21% |
---|---|
Current Year | -2.14 |
Next Year | -2.18 |
EPS (TTM) | -2.78 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.53 | -2.14 | -2.18 |
# of Estimates | 5 | 5 | 6 | 5 |
Most Recent Consensus | -0.48 | -0.59 | -2.14 | -2.93 |
High Estimate | -0.43 | -0.44 | -1.94 | -1.71 |
Low Estimate | -0.52 | -0.59 | -2.44 | -2.93 |
Year ago EPS | -0.92 | -0.79 | -3.30 | -2.14 |
Year over Year Growth Est. | 47.83% | 32.91% | 35.15% | -1.87% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 3 | 3 | 4 | 4 |
Up Last 60 Days | 3 | 3 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 1 | 0 |
Down Last 60 Days | 1 | 2 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.53 | -2.14 | -2.18 |
7 Days Ago | -0.48 | -0.53 | -2.14 | -2.18 |
30 Days Ago | -0.55 | -0.56 | -2.31 | -2.37 |
60 Days Ago | -0.55 | -0.56 | -2.31 | -2.37 |
90 Days Ago | -0.55 | -0.56 | -2.31 | -2.37 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.49 | -0.53 | -2.08 | -2.16 |
Zacks Consensus Estimate | -0.48 | -0.53 | -2.14 | -2.18 |
Earnings ESP | -0.21% | 0.00% | 2.80% | 0.80% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.45 | -0.62 | -0.79 | -0.92 | NA |
Estimate | -0.57 | -0.67 | -0.78 | -0.85 | NA |
Difference | 0.12 | 0.05 | -0.01 | -0.07 | 0.02 |
Surprise | 21.05% | 7.46% | -1.28% | -8.24% | 4.75% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more